Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2013-05-20

Clinical Trial Update: Comparison of Subcutaneous Heparin and Enoxaparin for Deep Venous Thrombosis (DVT) Prophylaxis in Surgical Intensive Care Patients [NA]

View source ↗

Summary

This clinical trial update indicates the study comparing subcutaneous heparin with enoxaparin for deep vein thrombosis prophylaxis in surgical intensive care pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Enoxaparin (enoxaparin sodium)
  • Heparin (unfractionated heparin)

Snippet

Sponsor: Lisa Louwers | Conditions: Lower Extremity Deep Venous Thrombosis | NA | Status: WITHDRAWN